asparaginase/cytarabine/imatinib mesylate

Known as: ARA-C/ASP/STI571 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2008
01220022008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Imatinib mesylate--Gleevec (US), Glivec (worldwide), STI571--is an oral cancer drug that selectively inhibits several protein… (More)
Is this relevant?
2006
2006
To study the effects of tyrosine-kinase inhibitor STI571 on the adhesion of RPMI8226 cells to fibronectin (FN), cell adhesion… (More)
Is this relevant?
Review
2004
Review
2004
The hematopoietic class III receptor tyrosine kinase (RTK) Flt3 (Flk2, STK1) has recently received much attention as a potential… (More)
Is this relevant?
2003
2003
The purpose of this study was to evaluate the activity of the indolinone kinase inhibitor SU11248 against the receptor tyrosine… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2003
Review
2003
Die chronisch myeloische Leukämie (CML) ist eine Stammzellerkrankung, die durch eine exzessive Akkumulation myeloischer Zellen… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2002
Review
2002
Many components of mitogenic signaling pathways in normal and neoplastic cells have been identified, including the large family… (More)
Is this relevant?
Review
2002
Review
2002
Abl family nonreceptor tyrosine kinases regulate cell morphogenesis through functional interactions with the actin cytoskeleton… (More)
Is this relevant?